81
XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a
Norwegian cohort: a case control study. BMC Cancer, 6, 67, 2006.
SMITH, T.R.; MILLER, M.S.; LOHMAN, K.; LANGE, E.M.; CASE, L.D.;
MOHRENWEISER, H.W.; HU, J.J. Polymorphisms of XRCC1 and XRCC3 genes and
susceptibility to breast cancer. Cancer Letters, 190, 2, 183-190, 2003.
SNUSTAND, D.P.; SIMMONS, M.J. Fundamentos de Genética. 2ª edição. Rio de
Janeiro: Editora Guanabara Koogan, 2001.756.
STEVENS, E. V.; RAFFELD, M.; ESPINA, V.; KRISTENSEN, G.B.; TROPE, C.G.;
KOHN, E.C.; DAVIDSON, B. Expression of Xeroderma Pigmentosum A Protein predicts
improved outcome in metastatic ovarian carcinoma. Cancer, 103, 11, 2313-2319, 2005.
STEWART, D.J. Mechanisms of resistance to cisplatin and carboplatin. Critical Reviews
in Oncology Hematology, 63, 1,12-31, 2007.
STUCKI, M.; PASCUCCI, B.; PARLANTI, E.; FORTINI, P.; WILSON, S.H.;
HÜBSCHER, U.; DOGLIOTTI, E. Mammalian base excision repair by DNA polymerases
delta and epsilon. Oncogene, 17, 835 – 843, 1998.
STURGIS, E.M.; CASTILLO, E.J.; LI, L.; ZHENG, R.; EICHER, S.A.; CLAYMAN,
G.L.; STROM, S.S.; SPITZ, M.R.; WEI, Q. Polymorphisms of DNA repair genes XRCC1
in squamous cell carcinoma of the head and neck. Carcinogenesis, 20, 2125-2129, 1999.
STURGIS, E.M.; WEI, Q.; SPITZ, M.R. Descriptive epidemiology and risk factors for
head and neck cancer. Seminars in Oncology, 31, 726-733, 2004.
TAKAOKA, S.; IWASE, M.; UCHIDA, M.; YOSHIBA, S.; KONDO, G.; WATANABE,
H.; OHASHI, M.; NAGUMO, M.; SHINTANI, S. Effect of combining epidermal growth
factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell
carcinoma cells. International Journal of Oncology, 30, 6, 1469-76, 2007.